Application of z-score-based quantification of muscle echogenicity for the diagnosis of sarcopenia in patients with rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory joint disease characterized by progressive joint destruction and systemically increased levels of inflammatory cytokines, resulting in an increased risk of sarcopenia. Previously, we reported that quantitative muscle ultrasound (US) was efficacious for the diagnosis of sarcopenia associated with RA. However, measured muscle echo intensity (EI) required complex processing to correct for overlying subcutaneous fat. The z-score-based quantification of muscle EI has been proposed and applied to various muscle disorders, enabling more accurate and convenient assessment of echogenicity by comparing with the estimated normal value of matched population. In this study, we evaluated the efficacy of z-score-based quantification of muscle EI for the diagnosis of sarcopenia in patients with RA. As a result, the median z-score of EI for the biceps brachii and rectus femoris in patients with sarcopenia was significantly higher than that in those without sarcopenia. The discriminative performance of z-score-based quantification for the diagnosis of sarcopenia was numerically higher than that of recorrected EI used in our previous study. In addition, z-score-based method was more convenient for the analysis because it could be easily calculated from patient’s age, subcutaneous fat thickness, and measured EI. These findings suggests that z-score-based quantification of muscle EI may offer a more convenient and accurate assessment of muscle pathology associated with sarcopenia in patients with RA.
